Skip to main content
SpringerLink
Log in

Malignancy

  • Chapter
  • First Online:
Surgical Metabolism

  • 1398 Accesses

Abstract

Nutrition and diet play a major role in cancer. Malnutrition and weight loss often contribute to the death of cancer patients. Nutritional abnormalities in cancer are unique and are a result of abnormal anatomic and physiologic circumstances. Factors that contribute to this are cancer cachexia, abnormalities in metabolism, and the cytokine milieu. Because of these abnormalities surgery in cancer patients can be more problematic. It is important to perform a formal nutritional assessment on patients with cancer and develop unique treatment plans to address deficiencies in the perioperative setting. Additionally, special nutritional considerations must be made to address malignancies affecting specific organ sites.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. PubMed PMID: 23335087.

    Article  PubMed  Google Scholar 

  2. Eaton L. World cancer rates set to double by 2020. BMJ. 2003;326(7392):728. PubMed PMID: 12676827; Pubmed Central PMCID: 1125643.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. J Clin Oncol. 2007;25(2): 180–6. PubMed PMID: 17210937.

    Article  PubMed  Google Scholar 

  4. August D, Huhmann M. Nutritional care of cancer patients. In: Norton J, Barie P, Bollinger R, Chang A, Lowry S, Mulvihill S, et al., editors. Surgery: basic science and clinical evidence. 2nd ed. New York: Springer; 2008. p. 2123–49.

    Chapter  Google Scholar 

  5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49. PubMed PMID: 19474385. Epub 2009/05/29. eng.

    Article  PubMed  Google Scholar 

  6. Warren S. The immediate cause of death in cancer. Am J Med Sci. 1932;185:610–5.

    Article  Google Scholar 

  7. Inagaki J, Rodriguez V, Bodey GP. Proceedings: Causes of death in cancer patients. Cancer. 1974;33(2):568–73. PubMed PMID: 4591273.

    Article  CAS  PubMed  Google Scholar 

  8. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66(6):1191–308. PubMed PMID: 7017215.

    CAS  PubMed  Google Scholar 

  9. Willett WC. Diet, nutrition, and avoidable cancer. Environ Health Perspect. 1995;103 Suppl 8:165–70. PubMed PMID: 8741778; Pubmed Central PMCID: 1518978.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Polednak AP. Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detect Prev. 2008;32(3):190–9. PubMed PMID: 18790577.

    Google Scholar 

  11. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–41. PubMed PMID: 22700443.

    Article  PubMed  Google Scholar 

  12. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):243–74. PubMed PMID: 22539238.

    Article  PubMed  Google Scholar 

  13. DeWys WD. Anorexia as a general effect of cancer. Cancer. 1979;43(5 Suppl):2013–9. PubMed PMID: 376105.

    Article  CAS  PubMed  Google Scholar 

  14. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69(4):491–7. PubMed PMID: 7424938.

    Article  CAS  PubMed  Google Scholar 

  15. Tan BH, Fearon KC. Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care. 2008;11(4):400–7. PubMed PMID: 18541999.

    Article  PubMed  Google Scholar 

  16. McClement S. Cancer anorexia-cachexia syndrome: psychological effect on the patient and family. J Wound Ostomy Continence Nurs. 2005;32(4):264–8. PubMed PMID: 16030467.

    Article  PubMed  Google Scholar 

  17. Ottery FD. Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol. 1995;22(2 Suppl 3):98–111. PubMed PMID: 7740324.

    CAS  PubMed  Google Scholar 

  18. Puccio M, Nathanson L. The cancer cachexia syndrome. Semin Oncol. 1997;24(3):277–87. PubMed PMID: 9208884. Epub 1997/06/01. eng.

    CAS  PubMed  Google Scholar 

  19. Studley H. Percentage of weight loss. JAMA. 1936;106:458–60.

    Article  Google Scholar 

  20. Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF, et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2008;15(8):2164–72. PubMed PMID: 18548313.

    Article  PubMed  Google Scholar 

  21. Lis CG, Gupta D, Lammersfeld CA, Markman M, Vashi PG. Role of nutritional status in predicting quality of life outcomes in cancer–a systematic review of the epidemiological literature. Nutr J. 2012;11:27. PubMed PMID: 22531478; Pubmed Central PMCID: 3408376.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38.

    Article  PubMed  Google Scholar 

  23. August DA, Huhmann MB. Nutritional support of the cancer patient. In: Ross CA, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, editors. Modern nutrition in health and disease. Philadelphia, PA: Lippincott, Williams and Wilkins; 2013. p. 1194–213.

    Google Scholar 

  24. Kern KA, Norton JA. Cancer cachexia. JPEN J Parenter Enteral Nutr. 1988;12(3):286–98. PubMed PMID: 3292798.

    Article  CAS  PubMed  Google Scholar 

  25. Arbeit JM, Lees DE, Corsey R, Brennan MF. Resting energy expenditure in controls and cancer patients with localized and diffuse disease. Ann Surg. 1984;199(3):292–8. PubMed PMID: 6703790; Pubmed Central PMCID: 1353395.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Hyltander A, Drott C, Korner U, Sandstrom R, Lundholm K. Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer. 1991;27(1):9–15. PubMed PMID: 1826450.

    Article  CAS  PubMed  Google Scholar 

  27. Falconer JS, Fearon KC, Plester CE, Ross JA, Carter DC. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg. 1994;219(4):325–31. PubMed PMID: 7512810; Pubmed Central PMCID: 1243147.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Reeves MM, Battistutta D, Capra S, Bauer J, Davies PS. Resting energy expenditure in patients with solid tumors undergoing anticancer therapy. Nutrition. 2006;22(6):609–15. PubMed PMID: 16704954.

    Article  PubMed  Google Scholar 

  29. Ravasco P, Monteiro-Grillo I, Camilo M. Colorectal cancer: intrinsic characteristics modulate cancer energy expenditure and the risk of cachexia. Cancer Invest. 2007;25(5):308–14. PubMed PMID: 17661205.

    Article  CAS  PubMed  Google Scholar 

  30. Cao DX, Wu GH, Zhang B, Quan YJ, Wei J, Jin H, et al. Resting energy expenditure and body composition in patients with newly detected cancer. Clin Nutr. 2010;29(1):72–7. PubMed PMID: 19647909.

    Article  PubMed  Google Scholar 

  31. Knox LS, Crosby LO, Feurer ID, Buzby GP, Miller CL, Mullen JL. Energy expenditure in malnourished cancer patients. Ann Surg. 1983;197(2):152–62. PubMed PMID: 6824369; Pubmed Central PMCID: 1353103.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Hansell DT, Davies JW, Burns HJ. The relationship between resting energy expenditure and weight loss in benign and malignant disease. Ann Surg. 1986;203(3):240–5. PubMed PMID: 3082302; Pubmed Central PMCID: 1251083.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Johnson G, Salle A, Lorimier G, Laccourreye L, Enon B, Blin V, et al. Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation. Nutrition. 2008;24(5):443–50. PubMed PMID: 18359195.

    Article  PubMed  Google Scholar 

  34. Vaisman N, Lusthaus M, Niv E, Santo E, Shacham-Shmueli E, Geva R, et al. Effect of tumor load on energy expenditure in patients with pancreatic cancer. Pancreas. 2012;41(2):230–2. PubMed PMID: 21926936.

    Article  PubMed  Google Scholar 

  35. Jebb SA, Osborne RJ, Dixon AK, Bleehen NM, Elia M. Measurements of resting energy expenditure and body composition before and after treatment of small cell lung cancer. Ann Oncol. 1994;5(10):915–9. PubMed PMID: 7696163.

    CAS  PubMed  Google Scholar 

  36. Simons JP, Schols AM, Buurman WA, Wouters EF. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci. 1999;97(2):215–23. PubMed PMID: 10409477.

    Article  CAS  PubMed  Google Scholar 

  37. Dempsey DT, Feurer ID, Knox LS, Crosby LO, Buzby GP, Mullen JL. Energy expenditure in malnourished gastrointestinal cancer patients. Cancer. 1984;53(6):1265–73. PubMed PMID: 6692317.

    Article  CAS  PubMed  Google Scholar 

  38. Fearon KC, Hansell DT, Preston T, Plumb JA, Davies J, Shapiro D, et al. Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer. Cancer Res. 1988;48(9):2590–5. PubMed PMID: 3356019.

    CAS  PubMed  Google Scholar 

  39. Fredrix EW, Wouters EF, Soeters PB, van der Aalst AC, Kester AD, von Meyenfeldt MF, et al. Resting energy expenditure in patients with non-small cell lung cancer. Cancer. 1991;68(7):1616–21. PubMed PMID: 1654199.

    Article  CAS  PubMed  Google Scholar 

  40. DuBois EF. Basal metabolism in health and disease. 3rd ed. Philadelphia: Lea and Febiger; 1936.

    Google Scholar 

  41. Kleiber M. The fire of life: an introduction to animal energetics. Malabar, FL: Krieger; 1961.

    Google Scholar 

  42. Harris JA. A biometric study of basal metabolism. Washington, DC: Carnegie Institute of Washington; 1919.

    Google Scholar 

  43. Barak N, Wall-Alonso E, Sitrin MD. Evaluation of stress factors and body weight adjustments currently used to estimate energy expenditure in hospitalized patients. JPEN J Parenter Enteral Nutr. 2002;26(4):231–8. PubMed PMID: 12090688.

    Article  PubMed  Google Scholar 

  44. MacDonald A, Hildebrandt L. Comparison of formulaic equations to determine energy expenditure in the critically ill patient. Nutrition. 2003;19(3):233–9. PubMed PMID: 12620525.

    Article  PubMed  Google Scholar 

  45. Bosy-Westphal A, Reinecke U, Schlorke T, Illner K, Kutzner D, Heller M, et al. Effect of organ and tissue masses on resting energy expenditure in underweight, normal weight and obese adults. Int J Obes Relat Metab Disord. 2004;28(1):72–9. PubMed PMID: 14647174.

    Article  CAS  PubMed  Google Scholar 

  46. Fearon KC. The Sir David Cuthbertson Medal Lecture 1991. The mechanisms and treatment of weight loss in cancer. Proc Nutr Soc. 1992;51(2):251–65. PubMed PMID: 1438334.

    Article  CAS  PubMed  Google Scholar 

  47. Agustsson T, Ryden M, Hoffstedt J, van Harmelen V, Dicker A, Laurencikiene J, et al. Mechanism of increased lipolysis in cancer cachexia. Cancer Res. 2007;67(11):5531–7. PubMed PMID: 17545636.

    Article  CAS  PubMed  Google Scholar 

  48. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009;89(2):381–410. PubMed PMID: 19342610.

    Article  CAS  PubMed  Google Scholar 

  49. Tisdale MJ. Cancer cachexia. Curr Opin Gastroenterol. 2010;26(2):146–51.

    Article  PubMed  Google Scholar 

  50. Shaw JH, Wolfe RR. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. The response to glucose infusion and parenteral feeding. Ann Surg. 1987;205(4):368–76. PubMed PMID: 3105476.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Laurencikiene J, Stenson BM, Arvidsson Nordstrom E, Agustsson T, Langin D, Isaksson B, et al. Evidence for an important role of CIDEA in human cancer cachexia. Cancer Res. 2008;68(22):9247–54.

    Article  CAS  PubMed  Google Scholar 

  52. Dilman VM, Berstein LM, Ostroumova MN, Tsyrlina YV, Golubev AG. Peculiarities of hyperlipidaemia in tumour patients. Br J Cancer. 1981;43(5): 637–43.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. Hussey HJ, Tisdale MJ. Effect of polyunsaturated fatty acids on the growth of murine colon adenocarcinomas in vitro and in vivo. Br J Cancer. 1994;70(1): 6–10. PubMed PMID: 8018542.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Tisdale MJ. Tumor-host interactions. J Cell Biochem. 2004;93(5):871–7.

    Article  CAS  PubMed  Google Scholar 

  55. Williams A, Sun X, Fischer JE, Hasselgren PO. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery. 1999;126(4):744–9. Discussion 9-50. PubMed PMID: 10520924.

    Article  CAS  PubMed  Google Scholar 

  56. Jeevanandam M, Legaspi A, Lowry SF, Horowitz GD, Brennan MF. Effect of total parenteral nutrition on whole body protein kinetics in cachectic patients with benign or malignant disease. JPEN J Parenter Enteral Nutr. 1988;12(3):229–36. PubMed PMID: 3134558.

    Article  CAS  PubMed  Google Scholar 

  57. Norton JA, Stein TP, Brennan MF. Whole body protein synthesis and turnover in normal man and malnourished patients with and without known cancer. Ann Surg. 1981;194(2):123–8. PubMed PMID: 6789786; Pubmed Central PMCID: 1345227.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  58. Lundholm K, Bennegard K, Eden E, Svaninger G, Emery PW, Rennie MJ. Efflux of 3-methylhistidine from the leg in cancer patients who experience weight loss. Cancer Res. 1982;42(11):4807–11. PubMed PMID: 7127315.

    CAS  PubMed  Google Scholar 

  59. Warren RS, Jeevanandam M, Brennan MF. Comparison of hepatic protein synthesis in vivo versus in vitro in the tumor-bearing rat. J Surg Res. 1987;42(1):43–50. PubMed PMID: 3543498.

    Article  CAS  PubMed  Google Scholar 

  60. Fearon KC, McMillan DC, Preston T, Winstanley FP, Cruickshank AM, Shenkin A. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg. 1991;213(1):26–31. PubMed PMID: 1898691; Pubmed Central PMCID: 1358306.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–14.

    Article  CAS  PubMed  Google Scholar 

  62. Bongaerts GP, van Halteren HK, Verhagen CA, Wagener DJ. Cancer cachexia demonstrates the energetic impact of gluconeogenesis in human metabolism. Med Hypotheses. 2006;67(5):1213–22. PubMed PMID: 16797873.

    Article  CAS  PubMed  Google Scholar 

  63. Lelbach A, Muzes G, Feher J. Current perspectives of catabolic mediators of cancer cachexia. Med Sci Monit. 2007;13(9):RA168–73. PubMed PMID: 17767131.

    CAS  PubMed  Google Scholar 

  64. Lundholm K, Edstrom S, Karlberg I, Ekman L, Schersten T. Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients. Cancer. 1982;50(6):1142–50. PubMed PMID: 7104955.

    Article  CAS  PubMed  Google Scholar 

  65. Waterhouse C, Jeanpretre N, Keilson J. Gluconeogenesis from alanine in patients with progressive malignant disease. Cancer Res. 1979;39(6 Pt 1):1968–72. PubMed PMID: 445395.

    CAS  PubMed  Google Scholar 

  66. Lundholm K, Holm G, Schersten T. Insulin resistance in patients with cancer. Cancer Res. 1978;38(12):4665–70. PubMed PMID: 719645.

    CAS  PubMed  Google Scholar 

  67. Rofe AM, Bourgeois CS, Coyle P, Taylor A, Abdi EA. Altered insulin response to glucose in weight-losing cancer patients. Anticancer Res. 1994;14(2B):647–50. PubMed PMID: 8010722.

    CAS  PubMed  Google Scholar 

  68. Smiechowska J, Utech A, Taffet G, Hayes T, Marcelli M, Garcia JM. Adipokines in patients with cancer anorexia and cachexia. J Invest Med. 2010;58(3):554–9. PubMed PMID: 20215915.

    CAS  Google Scholar 

  69. Garcia-Martinez C, Costelli P, Lopez-Soriano FJ, Argiles JM. Is TNF really involved in cachexia? Cancer Invest. 1997;15(1):47–54. PubMed PMID: 9028389.

    Article  CAS  PubMed  Google Scholar 

  70. Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A. Cancer cachexia–pathophysiology and management. J Gastroenterol. 2013;48(5):574–94. PubMed PMID: 23512346; Pubmed Central PMCID: 3698426.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  71. Toomey D, Redmond HP, Bouchier-Hayes D. Mechanisms mediating cancer cachexia. Cancer. 1995;76(12):2418–26. PubMed PMID: 8625066.

    Article  CAS  PubMed  Google Scholar 

  72. Lenk K, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle. 2010;1(1):9–21. PubMed PMID: 21475693; Pubmed Central PMCID: 3060644.

    Article  PubMed Central  PubMed  Google Scholar 

  73. Darling G, Fraker DL, Jensen JC, Gorschboth CM, Norton JA. Cachectic effects of recombinant human tumor necrosis factor in rats. Cancer Res. 1990;50(13):4008–13. PubMed PMID: 2354450.

    CAS  PubMed  Google Scholar 

  74. Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, et al. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987;50(4):555–63. PubMed PMID: 3607879.

    Article  CAS  PubMed  Google Scholar 

  75. Ramos EJ, Suzuki S, Marks D, Inui A, Asakawa A, Meguid MM. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care. 2004;7(4):427–34.

    Article  CAS  PubMed  Google Scholar 

  76. Tracey KJ, Morgello S, Koplin B, Fahey 3rd TJ, Fox J, Aledo A, et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J Clin Invest. 1990;86(6):2014–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  77. Matthys P, Dijkmans R, Proost P, Van Damme J, Heremans H, Sobis H, et al. Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells. Int J Cancer. 1991;49(1):77–82.

    Article  CAS  PubMed  Google Scholar 

  78. Fischer E, Marano MA, Barber AE, Hudson A, Lee K, Rock CS, et al. Comparison between effects of interleukin-1 alpha administration and sublethal endotoxemia in primates. Am J Physiol. 1991;261(2 Pt 2):R442–52.

    CAS  PubMed  Google Scholar 

  79. Gelin J, Moldawer LL, deMan P, Svanborg-Eden C, Lowry SF, et al. Appearance of hybridoma growth factor/interleukin-6 in the serum of mice bearing a methylcholanthrene-induced sarcoma. Biochem Biophys Res Commun. 1988;157(2):575–9.

    Article  CAS  PubMed  Google Scholar 

  80. Argiles JM, Lopez-Soriano FJ. The role of cytokines in cancer cachexia. Med Res Rev. 1999;19(3): 223–48.

    Article  CAS  PubMed  Google Scholar 

  81. Diakowska D, Krzystek-Korpacka M, Markocka-Maczka K, Diakowski W, Matusiewicz M, Grabowski K. Circulating leptin and inflammatory response in esophageal cancer, esophageal cancer-related cachexia-anorexia syndrome (CAS) and non-malignant CAS of the alimentary tract. Cytokine. 2010;51(2):132–7.

    Article  CAS  PubMed  Google Scholar 

  82. Yakabi K, Sadakane C, Noguchi M, Ohno S, Ro S, Chinen K, et al. Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology. 2010;151(8):3773–82.

    Article  CAS  PubMed  Google Scholar 

  83. Schreiber R, Selbach K, Asmussen M, Hesse D, de Vry J. Effects of serotonin(1/2) receptor agonists on dark-phase food and water intake in rats. Pharmacol Biochem Behav. 2000;67(2):291–305.

    Article  CAS  PubMed  Google Scholar 

  84. Monitto CL, Dong SM, Jen J, Sidransky D. Characterization of a human homologue of proteolysis-inducing factor and its role in cancer cachexia. Clin Cancer Res. 2004;10(17):5862–9.

    Article  CAS  PubMed  Google Scholar 

  85. Todorov PT, McDevitt TM, Meyer DJ, Ueyama H, Ohkubo I, Tisdale MJ. Purification and characterization of a tumor lipid-mobilizing factor. Cancer Res. 1998;58(11):2353–8.

    CAS  PubMed  Google Scholar 

  86. Bozzetti F. Effects of artificial nutrition on the nutritional status of cancer patients. JPEN J Parenter Enteral Nutr. 1989;13(4):406–20.

    Article  CAS  PubMed  Google Scholar 

  87. Wang Y, Jiang ZM, Nolan MT, Jiang H, Han HR, Yu K, et al. The impact of glutamine dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: a meta-analysis of randomized clinical trials. JPEN J Parenter Enteral Nutr. 2010;34(5):521–9.

    Article  CAS  PubMed  Google Scholar 

  88. Coster J, McCauley R, Hall J. Glutamine: metabolism and application in nutrition support. Asia Pac J Clin Nutr. 2004;13(1):25–31.

    CAS  PubMed  Google Scholar 

  89. Savarese DM, Savy G, Vahdat L, Wischmeyer PE, Corey B. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev. 2003; 29(6):501–13.

    Article  CAS  PubMed  Google Scholar 

  90. DeBerardinis RJ, Cheng T. Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2010;29(3):313–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  91. Eagle H. Nutrition needs of mammalian cells in tissue culture. Science. 1955;122(3168):501–14.

    Article  CAS  PubMed  Google Scholar 

  92. O’Riordain MG, Fearon KC, Ross JA, Rogers P, Falconer JS, Bartolo DC, et al. Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg. 1994;220(2):212–21.

    Article  PubMed Central  PubMed  Google Scholar 

  93. Kuhn KS, Muscaritoli M, Wischmeyer P, Stehle P. Glutamine as indispensable nutrient in oncology: experimental and clinical evidence. Eur J Nutr. 2010;49(4):197–210.

    Article  CAS  PubMed  Google Scholar 

  94. Wu GH, Zhang YW, Wu ZH. Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastrointestinal cancer patients. World J Gastroenterol. 2001;7(3): 357–62.

    CAS  PubMed  Google Scholar 

  95. Coghlin Dickson TM, Wong RM, Offrin RS, Shizuru JA, Johnston LJ, Hu WW, et al. Effect of oral glutamine supplementation during bone marrow transplantation. JPEN J Parenter Enteral Nutr. 2000;24(2): 61–6.

    Article  CAS  PubMed  Google Scholar 

  96. Morlion BJ, Stehle P, Wachtler P, Siedhoff HP, Koller M, Konig W, et al. Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg. 1998;227(2):302–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  97. Piccirillo N, De Matteis S, Laurenti L, Chiusolo P, Sora F, Pittiruti M, et al. Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica. 2003;88(2):192–200.

    CAS  PubMed  Google Scholar 

  98. Scheid C, Hermann K, Kremer G, Holsing A, Heck G, Fuchs M, et al. Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy. Nutrition. 2004;20(3):249–54.

    Article  CAS  PubMed  Google Scholar 

  99. Schloerb PR, Skikne BS. Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. JPEN J Parenter Enteral Nutr. 1999;23(3):117–22.

    Article  CAS  PubMed  Google Scholar 

  100. Heys SD, Gough DB, Khan L, Eremin O. Nutritional pharmacology and malignant disease: a therapeutic modality in patients with cancer. Br J Surg. 1996; 83(5):608–19.

    Article  CAS  PubMed  Google Scholar 

  101. De Luis DA, Izaola O, Cuellar L, Terroba MC, Martin T, Aller R. High dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients. A randomized clinical trial. Eur Rev Med Pharmacol Sci. 2009;13(4):279–83.

    PubMed  Google Scholar 

  102. Buijs N, van Bokhorst-de van der Schueren MA, Langius JA, Leemans CR, Kuik DJ, Vermeulen MA, et al. Perioperative arginine-supplemented nutrition in malnourished patients with head and neck cancer improves long-term survival. Am J Clin Nutr. 2010;92(5):1151–6.

    Article  CAS  PubMed  Google Scholar 

  103. Lacour J, Laplanche A, Delozier T, Berlie J, Mourali N, Julien JP, et al. Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapy versus chemotherapy with CMF as adjuvants in operable breast cancer. A 6 1/2 year follow-up analysis of a randomized trial of the French Federation of Cancer Centers (F.F.C.C.). Breast Cancer Res Treat. 1991;19(1):15–21.

    Google Scholar 

  104. Lacour J, Laplanche A, Malafosse M, Gallot D, Julien M, Rotman N, et al. Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal carcinoma: a 6 1/2 year follow-up analysis of a multicentric double blind randomized trial. Eur J Surg Oncol. 1992;18(6):599–604.

    CAS  PubMed  Google Scholar 

  105. Moses AW, Slater C, Preston T, Barber MD, Fearon KC. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 2004;90(5):996–1002.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  106. Heslin MJ, Latkany L, Leung D, Brooks AD, Hochwald SN, Pisters PW, et al. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg. 1997;226(4):567–77. Discussion 77-80.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  107. Braga M, Gianotti L, Cestari A, Vignali A, Pellegatta F, Dolci A, et al. Gut function and immune and inflammatory responses in patients perioperatively fed with supplemented enteral formulas. Arch Surg. 1996;131(12):1257–64. Discussion 64-5.

    Article  CAS  PubMed  Google Scholar 

  108. Braga M, Gianotti L, Vignali A, Cestari A, Bisagni P, Di Carlo V. Artificial nutrition after major abdominal surgery: impact of route of administration and composition of the diet. Crit Care Med. 1998;26(1): 24–30.

    Article  CAS  PubMed  Google Scholar 

  109. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology. 2002;122(7):1763–70.

    Article  CAS  PubMed  Google Scholar 

  110. Braga M, Vignali A, Zuliani W, Radaelli G, Gianotti L, Martani C, et al. Metabolic and functional results after laparoscopic colorectal surgery: a randomized, controlled trial. Dis Colon Rectum. 2002;45(8): 1070–7.

    Article  PubMed  Google Scholar 

  111. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286(8):944–53.

    Article  CAS  PubMed  Google Scholar 

  112. Marik PE, Zaloga GP. Immunonutrition in high-risk surgical patients: a systematic review and analysis of the literature. JPEN J Parenter Enteral Nutr. 2010; 34(4):378–86.

    Article  PubMed  Google Scholar 

  113. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med. 1991;325(8):525–32.

    Google Scholar 

  114. Huhmann MB, August DA. Perioperative nutrition support in cancer patients. Nutr Clin Pract. 2012;27(5):586–92.

    Article  PubMed  Google Scholar 

  115. Jensen GL. Inflammation as the key interface of the medical and nutrition universes: a provocative examination of the future of clinical nutrition and medicine. JPEN J Parenter Enteral Nutr. 2006;30(5):453–63.

    Article  PubMed  Google Scholar 

  116. Hirsch S, de Obaldia N, Petermann M, Covacevic S, Burmeister R, Llorens P, et al. Nutritional status of surgical patients and the relationship of nutrition to postoperative outcome. J Am Coll Nutr. 1992; 11(1):21–4.

    Article  CAS  PubMed  Google Scholar 

  117. Directors ABo, the Clinical Guidelines Task F. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26(1 Suppl):1SA–138SA.

    Google Scholar 

  118. Identifying patients at risk: ADA’s definitions for nutrition screening and nutrition assessment. Council on Practice (COP) Quality Management Committee. J Am Diet Assoc. 1994;94(8):838–9.

    Google Scholar 

  119. Mueller C, Compher C, Ellen DM, American Society for Parenteral and Enteral Nutrition Board of Directors. A.S.P.E.N. Clinical Guidelines: Nutrition screening, assessment, and intervention in adults. JPEN J Parenter Enteral Nutr. 2011;35(1):16–24.

    Article  PubMed  Google Scholar 

  120. Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition. 1996;12(1 Suppl):S15–9.

    Article  CAS  PubMed  Google Scholar 

  121. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr. 1987;11(1):8–13. PubMed PMID: 3820522.

    Article  CAS  PubMed  Google Scholar 

  122. Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: the mini nutritional assessment as part of the geriatric evaluation. Nutr Rev. 1996;54(1 Pt 2):S59–65. PubMed PMID: 8919685.

    CAS  PubMed  Google Scholar 

  123. Ferguson M, Capra S, Bauer J, Banks M. Development of a valid and reliable malnutrition screening tool for adult acute hospital patients. Nutrition. 1999;15(6):458–64. PubMed PMID: 10378201.

    Article  CAS  PubMed  Google Scholar 

  124. Ferguson ML, Bauer J, Gallagher B, Capra S, Christie DR, Mason BR. Validation of a malnutrition screening tool for patients receiving radiotherapy. Australas Radiol. 1999;43(3):325–7. PubMed PMID: 10901927.

    Article  CAS  PubMed  Google Scholar 

  125. Malnutrition Advisory Group. A consistent and reliable tool for malnutrition screening. Nurs Times. 2003;99(46):26–7. PubMed PMID: 14666817.

    Google Scholar 

  126. Bauer J, Capra S. Comparison of a malnutrition screening tool with subjective global assessment in hospitalised patients with cancer–sensitivity and specificity. Asia Pac J Clin Nutr. 2003;12(3):257–60. PubMed PMID: 14505986.

    PubMed  Google Scholar 

  127. Kondrup J, Johansen N, Plum LM, Bak L, Larsen IH, Martinsen A, et al. Incidence of nutritional risk and causes of inadequate nutritional care in hospitals. Clin Nutr. 2002;21(6):461–8. PubMed PMID: 12468365.

    Article  CAS  PubMed  Google Scholar 

  128. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002;56(8):779–85. PubMed PMID: 12122555.

    Article  CAS  PubMed  Google Scholar 

  129. Ferguson M. Patient-generated subjective global assessment. Oncology. 2003;17(2 Suppl 2):13–4. Discussion 14–6. PubMed PMID: 12632872.

    PubMed  Google Scholar 

  130. August DA, Huhmann MB, American Society for Parenteral and Enteral Nutrition Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr. 2009;33(5):472–500.

    Article  PubMed  Google Scholar 

  131. Meijerink WJ, von Meyenfeldt MF, Rouflart MM, Soeters PB. Efficacy of perioperative nutritional support. Lancet. 1992;340(8812):187–8. PubMed PMID: 1352609.

    Article  CAS  PubMed  Google Scholar 

  132. Foschi D, Cavagna G, Callioni F, Morandi E, Rovati V. Hyperalimentation of jaundiced patients on percutaneous transhepatic biliary drainage. Br J Surg. 1986;73(9):716–9. PubMed PMID: 3092894.

    Article  CAS  PubMed  Google Scholar 

  133. Senkal M, Zumtobel V, Bauer KH, Marpe B, Wolfram G, Frei A, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg. 1999;134(12):1309–16. PubMed PMID: 10593328.

    Article  CAS  PubMed  Google Scholar 

  134. Braga M, Gianotti L, Nespoli L, Radaelli G, Di Carlo V. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg. 2002;137(2):174–80. PubMed PMID: 11822956.

    Article  PubMed  Google Scholar 

  135. August DA, Kushner RF. The 1995 A.S.P.E.N. standards for nutrition support: hospitalized patients. Nutr Clin Pract. 1995;10(6):206–7.

    Article  CAS  PubMed  Google Scholar 

  136. Foschi D, Toti GL, Del Soldato P, Ferrante F, Galeone M, Rovati V. Adaptive cytoprotection: an endoscopic study in man. Am J Gastroenterol. 1986;81(11):1035–7. PubMed PMID: 3776949.

    CAS  PubMed  Google Scholar 

  137. Borea G, Ceccarelli C, Rinaldi-Ceroni A, Galie M, Stancari V, Rivano MT, et al. Adenolymphomas of the parotid gland. Immunocytochemical study. Pathologica. 1986;78(1057):545–53.

    CAS  PubMed  Google Scholar 

  138. Turi A, Di Prospero F, Foschi F, Campanari G, Romanini C. [Changes in the circulation pattern of serum melatonin in women with ovarian neoplasms]. Annali di ostetricia, ginecologia, medicina perinatale. 1986;107(4):207–9.

    Google Scholar 

  139. Trabucchi E, Foschi D, Colombo R, Baratti C, Del Soldato P, Centemero A, et al. Cytoprotection by PGE2, pirenzepine or vagotomy: a transmission and scanning electron microscopic study in rats. Pharmacol Res Commun. 1986;18(4):357–69.

    Article  CAS  PubMed  Google Scholar 

  140. Del Soldato P, Foschi D, Benoni G, Scarpignato C. Oxygen free radicals interact with indomethacin to cause gastrointestinal injury. Agents Actions. 1986;17(5–6):484–8.

    Article  PubMed  Google Scholar 

  141. Foschi D, Ferrante F, Varin L, Del Soldato P, Rovati V. Protection of gastric mucosa in rats. Differences between vagotomy, atropine, and PGE2. Dig Dis Sci. 1986;31(3):289–96.

    Article  CAS  PubMed  Google Scholar 

  142. Morrison MH, Barber HE, Foschi PG, Hawksworth GM. The kinetics of 4-nitrophenol conjugation by perfused livers and hepatic microsomes from streptozocin-induced diabetic rats. J Pharm Pharmacol. 1986;38(3):188–94.

    Article  CAS  PubMed  Google Scholar 

  143. Carli P, De Giorgi V, Chiarugi A, Stante M, Giannotti B. Multiple synchronous cutaneous melanomas: implications for prevention. Int J Dermatol. 2002;41(9):583–5.

    Article  PubMed  Google Scholar 

  144. Patrono C, Dionisi-Vici C, Giannotti A, Bembi B, Digilio MC, Rizzo C, et al. Two novel mutations of the human delta7-sterol reductase (DHCR7) gene in children with Smith-Lemli-Opitz syndrome. Mol Cell Probes. 2002;16(4):315–8.

    Article  CAS  PubMed  Google Scholar 

  145. Carli P, De Giorgi V, Argenziano G, Palli D, Giannotti B. Pre-operative diagnosis of pigmented skin lesions: in vivo dermoscopy performs better than dermoscopy on photographic images. J Eur Acad Dermatol Venereol. 2002;16(4):339–46.

    Article  CAS  PubMed  Google Scholar 

  146. Prignano F, Coronnello M, Pimpinelli N, Cappugi P, Mini E, Giannotti B. Immunophenotypical markers, ultrastructure and chemosensitivity profile of metastatic melanoma cells. Cancer Lett. 2002;186(2): 183–92.

    Article  CAS  PubMed  Google Scholar 

  147. Giolitti A, Altamura M, Bellucci F, Giannotti D, Meini S, Patacchini R, et al. Monocyclic human tachykinin NK-2 receptor antagonists as evolution of a potent bicyclic antagonist: QSAR and site-directed mutagenesis studies. J Med Chem. 2002;45(16): 3418–29.

    Article  CAS  PubMed  Google Scholar 

  148. Giannotti B, Pimpinelli N. Modern diagnosis of cutaneous lymphoma. Recent Results Cancer Res. 2002;160:303–6.

    Article  CAS  PubMed  Google Scholar 

  149. Toscano A, Anaclerio S, Digilio MC, Giannotti A, Fariello G, Dallapiccola B, et al. Ventricular septal defect and deletion of chromosome 22q11: anatomical types and aortic arch anomalies. Eur J Pediatr. 2002;161(2):116–7. PubMed PMID: 11954747.

    Article  CAS  PubMed  Google Scholar 

  150. de Camargo OP, dos Santos Machado TM, Croci AT, de Oliveira CR, Giannotti MA, Baptista AM, et al. Primary bone lymphoma in 24 patients treated between 1955 and 1999. Clin Orthop Relat Res. 2002;397:271–80. PubMed PMID: 11953618.

    Article  PubMed  Google Scholar 

  151. Carli P, De Giorgi V, Nardini P, Mannone F, Palli D, Giannotti B. Melanoma detection rate and concordance between self-skin examination and clinical evaluation in patients attending a pigmented lesion clinic in Italy. Br J Dermatol. 2002;146(2):261–6.

    Article  CAS  PubMed  Google Scholar 

  152. Mangino M, Flex E, Digilio MC, Giannotti A, Dallapiccola B. Identification of a novel NOG gene mutation (P35S) in an Italian family with symphalangism. Hum Mutat. 2002;19(3):308.

    Article  CAS  PubMed  Google Scholar 

  153. Harmat NJ, Giannotti D, Nannicini R, Perrotta E, Criscuoli M, Patacchini R, et al. Insertion of 2-carboxysuccinate and tricarballylic acid fragments into cyclic-pseudopeptides: new antagonists for the human tachykinin NK-2 receptor. Bioorg Med Chem Lett. 2002;12(4):693–6.

    Article  CAS  PubMed  Google Scholar 

  154. Giannotti E, Vandin L, Repeto P, Comelli R. A comparison of the in vitro Comet assay with the in vitro chromosome aberration assay using whole human blood or Chinese hamster lung cells: validation study using a range of novel pharmaceuticals. Mutagenesis. 2002;17(2):163–70.

    Article  CAS  PubMed  Google Scholar 

  155. Gemma M, Tommasino C, Cerri M, Giannotti A, Piazzi B, Borghi T. Intracranial effects of endotracheal suctioning in the acute phase of head injury. J Neurosurg Anesthesiol. 2002;14(1):50–4.

    Article  PubMed  Google Scholar 

  156. Gianotti N, Setti M, Manconi PE, Leoncini F, Chiodo F, Minoli L, et al. Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART study. Int J Immunopathol Pharmacol. 2002;15(2):129–39.

    CAS  PubMed  Google Scholar 

  157. Gianotti L, Lanfranco F, Ramunni J, Destefanis S, Ghigo E, Arvat E. GH/IGF-I axis in anorexia nervosa. Eat Weight Disord. 2002;7(2):94–105.

    CAS  PubMed  Google Scholar 

  158. Veraldi S, Rigoni C, Gianotti R. Leishmaniasis of the lip. Acta dermato-venereologica. 2002;82(6):469–70.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rutgers Cancer Institute of New Jersey, Division of Surgical Oncology, Rutgers Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ, 08903-2601, USA

    Laleh G. Melstrom MD, MS, Vadim Koshenkov MD & David A. August MD

Authors
  1. Laleh G. Melstrom MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vadim Koshenkov MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David A. August MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA

    Kimberly A. Davis

  2. Department of Anesthesiology, Yale University School of Medicine, New Haven, Connecticut, USA

    Stanley H. Rosenbaum

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Melstrom, L.G., Koshenkov, V., August, D.A. (2014). Malignancy. In: Davis, K., Rosenbaum, S. (eds) Surgical Metabolism. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1121-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1121-9_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1120-2

  • Online ISBN: 978-1-4939-1121-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation